1.
Rev Neurol (Paris)
; 165(8-9): 671-5, 2009.
Artículo
en Francés
| MEDLINE
| ID: mdl-19447457
RESUMEN
In France, the risk of multiple sclerosis is considered medium to high risk. Several incidence and prevalence studies have been performed at regional and national levels. Prevalence is evaluated between 143 and 60 per 100 000 inhabitants. Prevalence of multiple sclerosis is higher in northeastern France. Incidence varies between 4.1 and 8.2 per 100 000 inhabitants depending on the region. In certain regions such as Lorraine, incidence among women seems to be on the rise.
Asunto(s)
Esclerosis Múltiple/epidemiología , Adulto , Factores de Edad , Femenino , Francia/epidemiología , Humanos , Masculino , Martinica/epidemiología , Medición de Riesgo , Factores Sexuales
2.
J Pediatr
; 139(3): 443-6, 2001 Sep.
Artículo
en Inglés
| MEDLINE
| ID: mdl-11562627
RESUMEN
We present a report of the use of interferon-beta before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated.